Carterra Enables Anthropic’s Autonomous AI Protein Design Study via its HT-SPR Binding Platforms
Salt Lake City, Utah, August 24, 2026: Carterra®, a leading [...]
FairJourney Bio delivers antibody engineering for novel tumor-conditional IL-12 therapeutic approach that unlocks the potential of localized cytokine activation
Study in mAbs describes the first reported demonstration of a [...]
Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model
Investment in new premises in London reflects significant milestone in [...]
Tagomics introduces LiquiPath, a first-in-class cfDNA-based blood test for multi-organ drug safety monitoring
Non-invasive cell-free DNA liquid biopsy platform for multi-organ monitoring of [...]
SynGenSys introduces expanded CHO.SET synthetic promoter library for enhanced biomanufacturing
CHO.SET® 2.0 library of synthetic promoters provide tuneable expression of [...]
CN Bio awarded Innovate UK grant to reduce animal use in pharmacokinetic studies
Grant funding delivered in partnership with the NC3Rs, in support [...]
Calla Lily Clinical Care selected to join Wellcome Leap’s $50M Focused Antibiotics Programme
Callavid intravaginal drug delivery platform selected to advance targeted UTI [...]
Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development
Extension of the INDUCE-seq platform to support adenine base editing [...]
DNA Script and leading healthcare solutions provider awarded up to $26M by ARPA-H to advance cell-free DNA bioproduction
FLASH program, in collaboration with GE HealthCare, to support development [...]
Qureight closes $20 million Series B financing
Round led by Molten Ventures alongside existing investors Hargreave Hale [...]